Table I.

Clinicopathological data of patients with PCa and BPH.

	Value
Characteristic	PCa	BPH
Total, n	29	16
Mean age, years (range)	68.14 (55–76)	68.25 (49–77)
Mean PSA (range)	56.004 (0.002–1000)	5.080 (0.343–12.035)
Clinical stage, n
T1c	2	N/A
T2c	11	N/A
T3a	6	N/A
T3b	8	N/A
T4b	2	N/A
Gleason score, n
3 + 3	6	N/A
3 + 4	6	N/A
4 + 3	8	N/A
4 + 4	6	N/A
4 + 5	2	N/A
5 + 4	1	N/A

PSA, prostate-specific antigen; PCa, prostate cancer; BPH, benign prostate hyperplasia.